Regional impairment of cerebral oxidative metabolism in Parkinson's disease
- PMID: 762585
- PMCID: PMC490159
- DOI: 10.1136/jnnp.42.1.59
Regional impairment of cerebral oxidative metabolism in Parkinson's disease
Abstract
Twenty-two patients affected by idiopathic Parkinsonism were studied using the oxygen-15 inhalation technique. The production of labelled metabolic water was found to be decreased in the parietal cerebral cortex, indicating an impairment in oxidative metabolism. This metabolic defect was localised mainly to the parietal cortex of the affected hemispheres; in non-affected hemispheres of patients presenting with unilateral Parkinsonism, the uptake was normal. In contrast, regional blood flow was not significantly altered. It is possible that this metabolic impairment is caused by chronic deafferentation.
Similar articles
-
Regional cerebral blood flow in patients with Parkinson's disease.Arch Neurol. 1979 Jun;36(6):344-8. doi: 10.1001/archneur.1979.00500420054005. Arch Neurol. 1979. PMID: 454231
-
Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.J Neurol Neurosurg Psychiatry. 1991 Oct;54(10):898-904. doi: 10.1136/jnnp.54.10.898. J Neurol Neurosurg Psychiatry. 1991. PMID: 1744644 Free PMC article.
-
The effects of L-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson's disease.Brain. 1985 Mar;108 ( Pt 1):171-91. doi: 10.1093/brain/108.1.171. Brain. 1985. PMID: 3978397
-
Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects.Prog Neurobiol. 2009 Jun;88(2):89-103. doi: 10.1016/j.pneurobio.2009.02.004. Epub 2009 Mar 9. Prog Neurobiol. 2009. PMID: 19482226 Review.
-
[Cerebral perfusion and oxygen metabolism in Parkinson's disease: positron emission tomographic study using oxygen-15-labeled CO2 and O2].Nihon Rinsho. 1997 Jan;55(1):218-21. Nihon Rinsho. 1997. PMID: 9014453 Review. Japanese.
Cited by
-
Cerebral glucose utilization in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1985 May;48(5):489. doi: 10.1136/jnnp.48.5.489-a. J Neurol Neurosurg Psychiatry. 1985. PMID: 3998760 Free PMC article. No abstract available.
-
Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.Front Aging Neurosci. 2019 Nov 8;11:302. doi: 10.3389/fnagi.2019.00302. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31787891 Free PMC article.
-
The development, past achievements, and future directions of brain PET.J Cereb Blood Flow Metab. 2012 Jul;32(7):1426-54. doi: 10.1038/jcbfm.2012.20. Epub 2012 Mar 21. J Cereb Blood Flow Metab. 2012. PMID: 22434067 Free PMC article. Review.
-
Three-dimensional surface display of brain perfusion with 123I-IMP in Parkinson's disease.Neuroradiology. 1994 May;36(4):276-80. doi: 10.1007/BF00593259. Neuroradiology. 1994. PMID: 8065570
-
Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.NPJ Parkinsons Dis. 2016 Feb 18;2:16001. doi: 10.1038/npjparkd.2016.1. eCollection 2016. NPJ Parkinsons Dis. 2016. PMID: 28725692 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources